ID: ALA2441092

Max Phase: Preclinical

Molecular Formula: C22H21NO4

Molecular Weight: 363.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(C(=O)Nc2cc(C)c(Oc3ccc(O)cc3)c(C)c2)c1

Standard InChI:  InChI=1S/C22H21NO4/c1-14-11-17(23-22(25)16-5-4-6-20(13-16)26-3)12-15(2)21(14)27-19-9-7-18(24)8-10-19/h4-13,24H,1-3H3,(H,23,25)

Standard InChI Key:  CGWSHFPCZCSZNN-UHFFFAOYSA-N

Associated Targets(Human)

Androgen Receptor 11781 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Androgen Receptor 399 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 363.41Molecular Weight (Monoisotopic): 363.1471AlogP: 5.06#Rotatable Bonds: 5
Polar Surface Area: 67.79Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.70CX Basic pKa: CX LogP: 5.13CX LogD: 5.13
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -0.83

References

1. Yamada A, Fujii S, Mori S, Kagechika H..  (2013)  Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists.,  (10): [PMID:24900588] [10.1021/ml4001744]

Source